<p>The National Cancer Institute issued a purchase order to MR Solutions Americas, LLC valued at $12,150 on September 11, 2018. Place of performance is Bethesda, Maryland. The order is a firm fixed-price commercial item acquisition with no set-aside applied. Ultimate completion is scheduled for October 11, 2018.</p>
<p>The National Cancer Institute awarded a purchase order to MR Solutions Inc. valued at $24,999.00 on August 2, 2018, with a completion date of September 12, 2019. No set-aside was used. Performance takes place in Acton, Massachusetts. MR Solutions Inc. manufactures advanced medical imaging equipment, including magnetic resonance imaging and positron emission tomography systems for research and medical applications.</p>
<p>The National Cancer Institute awarded a purchase order to MR Solutions Americas, LLC for $1,145,600.00 on September 12, 2018, under a Total Small Business set-aside for a brand name or equal MR Solutions microPET/1203CT scanner system. Performance is at Bethesda, Maryland. The order carries a firm fixed price and completion date of February 28, 2019. The solicitation was posted August 9, 2018, with a due date of August 17, 2018.</p>
The National Cancer Institute (NCI) awarded a purchase order to MR Solutions Inc. for preventive maintenance services on an MRS*PET/CT imaging scanner system, with a ceiling value of $244,510.05 and an award date of April 1, 2025. The originating solicitation designated this as a total small business set-aside under NAICS 811210, though the award is a direct procurement from the original equipment manufacturer. Work is performed at the NIH facility in Bethesda, Maryland. The order covers...
This is a $77,824 firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to MR Solutions Americas, LLC for preventative maintenance services on a government-owned MR Solutions microPET/CT imaging scanner located at the NIH campus in Bethesda, Maryland. The contract has a base period of 12 months and two 12-month option periods, for a potential total duration of approximately 3 years. This is an unrestricted commercial item...
<p>The National Cancer Institute awarded a purchase order to Bruker Biospin Corp for $697,395 on September 18, 2017, to acquire a 3T MRI system for dynamic metabolic imaging using dynamic nuclear polarization. Performance takes place in Billerica, Massachusetts. The order carries a firm fixed price and has an ultimate completion date of March 17, 2018. No set-aside was used.</p>
<p>The National Cancer Institute awarded a purchase order to Meta Systems Group Inc. valued at $10,900 on January 29, 2019, for firm fixed-price commercial items. Performance occurs in Bethesda, Maryland. The order covers advanced microscopy and scientific imaging equipment, including slide scanning and imaging platforms to support medical research and diagnostic analysis. The purchase order carries no set-aside designation. Ultimate completion was scheduled for January 31, 2020.</p>
<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>
<p>The National Cancer Institute awarded a purchase order to Menarini Silicon Biosystems, Inc. for $18,700.00 on August 24, 2017. Performance takes place in Bethesda, Maryland. The order carries a firm fixed price and was due for completion by January 27, 2018.</p>
<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>